Arbutus Biopharma Corporation (ABUS)
 NASDAQ: ABUS · Real-Time Price · USD
 4.840
 +0.230 (4.99%)
  Oct 30, 2025, 4:00 PM EDT - Market closed
Arbutus Biopharma Market Cap
Arbutus Biopharma has a market cap or net worth of $927.82 million as of October 30, 2025. Its market cap has increased by 27.33% in one year.
Market Cap 
 927.82M
Enterprise Value 
 834.73M
1-Year Change 
 27.33%
Ranking 
 Category 
 Stock Price 
$4.84
Market Cap Chart
Since December 31, 2009, Arbutus Biopharma's market cap has increased from $47.50M to $927.82M, an increase of 1,853.31%. That is a compound annual growth rate of 20.64%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 29, 2025 | 883.70M | 42.62% | 
| Dec 31, 2024 | 619.60M | 47.81% | 
| Dec 29, 2023 | 419.20M | 14.98% | 
| Dec 30, 2022 | 364.60M | -30.71% | 
| Dec 31, 2021 | 526.20M | 74.59% | 
| Dec 31, 2020 | 301.40M | 90.76% | 
| Dec 31, 2019 | 158.00M | -25.65% | 
| Dec 31, 2018 | 212.50M | -23.56% | 
| Dec 29, 2017 | 278.00M | 106.85% | 
| Dec 30, 2016 | 134.40M | -44.65% | 
| Dec 31, 2015 | 242.80M | -28.19% | 
| Dec 31, 2014 | 338.10M | 196.58% | 
| Dec 31, 2013 | 114.00M | 89.05% | 
| Dec 31, 2012 | 60.30M | 289.03% | 
| Dec 30, 2011 | 15.50M | -68.04% | 
| Dec 31, 2010 | 48.50M | 2.11% | 
| Dec 31, 2009 | 47.50M | - | 
| Dec 31, 2009 | 47.50M | - | 
View and export this data all the way back to 2009. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Eli Lilly and Company | 736.23B | 
| Johnson & Johnson | 449.42B | 
| AbbVie | 401.96B | 
| UnitedHealth Group | 333.14B | 
| AstraZeneca | 255.54B | 
| Novartis AG | 239.27B | 
| Novo Nordisk | 229.86B | 
| Abbott Laboratories | 220.36B |